MAA is easy to obtain. what is difficult is the After Market...

First 7 Last

Share
Profile

Follow
Astral

851 Posts.

34

19/01/19

17:56

Post #: 37165107
Share

Originally posted by Buckland ↑

CBD,

Sorry I didnt see your second post - please accept my apology my fault for not reading all posts.

So lipton thinks I am ignorant or my post ignorant and states I have no friends or no life what a load of crap posted by someone who doesnt know me but I can see from his post he is another one who can not accept that our investment an or our timing of investment was totally wrong.

That he is far to acceptable of a management that promises a lot but delivers very little - and imo one of the main reason companies can keep getting away with not performing as well as they say they will, what is needed is for shareholders to start demanding that company management stop over promising and start more delivering.

Facts:
MAA for Artimist still not obtained
MAA for Zolpimist not submitted
Teva's MAA still not approved
Still no milestone payments
Deal upfronts well below what the market was lead to believe they would be

So maybe I am ignorant but what does that make the rest of you who just keep making excuse after excuse

Expand

MAA is easy to obtain. what is difficult is the After Market Data you have to provide when your product is reviewed. If the product is not ready to be on the market shelfs it is prudent to not apply for MAA yet. The after market data review may affect the renewal of any MAA given.

SUD Price at posting: 0.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

This thread is closed.

You may not reply to this discussion at this time.

There are more pages in this discussion • 8 more messages in this thread...

First 7 Last

Add SUD (ASX) to my watchlist

MAA is easy to obtain. what is difficult is the After Market...

Top Stories

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game